Do analysts recommend RDHL or CMND?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Redhill Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, RDHL or CMND?

Redhill Biopharma has higher revenue and earnings than Clearmind Medicine. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Redhill Biopharma $290K 10.80 -$430K N/A N/A Clearmind Medicine N/A N/A -$3.86M -$40.55 N/A

Is RDHL or CMND more profitable?

Redhill Biopharma's return on equity of 0.00% beat Clearmind Medicine's return on equity. Company Net Margins Return on Equity Return on Assets Redhill Biopharma N/A N/A N/A Clearmind Medicine N/A -88.53% -61.62%

Does the media prefer RDHL or CMND?

In the previous week, Clearmind Medicine had 6 more articles in the media than Redhill Biopharma. MarketBeat recorded 9 mentions for Clearmind Medicine and 3 mentions for Redhill Biopharma. Clearmind Medicine's average media sentiment score of 0.55 beat Redhill Biopharma's score of 0.21 indicating that Clearmind Medicine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Redhill Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Clearmind Medicine 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CMND or CVKD?

Cadrenal Therapeutics has a consensus price target of $13.00, indicating a potential upside of 1,214.46%. Given Cadrenal Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Cadrenal Therapeutics is more favorable than Clearmind Medicine. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cadrenal Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings and valuation, CMND or CVKD?

Cadrenal Therapeutics is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clearmind Medicine N/A N/A -$3.86M -$40.55 N/A Cadrenal Therapeutics N/A N/A -$13.24M -$4.90 N/A

Is CMND or CVKD more profitable?

Clearmind Medicine's return on equity of -88.53% beat Cadrenal Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -88.53% -61.62% Cadrenal Therapeutics N/A -406.41% -273.80%

Does the media favor CMND or CVKD?

In the previous week, Clearmind Medicine had 6 more articles in the media than Cadrenal Therapeutics. MarketBeat recorded 8 mentions for Clearmind Medicine and 2 mentions for Cadrenal Therapeutics. Cadrenal Therapeutics' average media sentiment score of 0.55 beat Clearmind Medicine's score of 0.55 indicating that Cadrenal Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cadrenal Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CMND or XRTX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 XORTX Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, CMND or XRTX?

XORTX Therapeutics is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clearmind Medicine N/A N/A -$3.86M -$40.55 N/A XORTX Therapeutics N/A N/A -$2.66M -$2.73 N/A

Is CMND or XRTX more profitable?

Clearmind Medicine's return on equity of -88.53% beat XORTX Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -88.53% -61.62% XORTX Therapeutics N/A -137.85% -108.16%

Does the media prefer CMND or XRTX?

In the previous week, Clearmind Medicine had 4 more articles in the media than XORTX Therapeutics. MarketBeat recorded 8 mentions for Clearmind Medicine and 4 mentions for XORTX Therapeutics. XORTX Therapeutics' average media sentiment score of 1.02 beat Clearmind Medicine's score of 0.55 indicating that XORTX Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive XORTX Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CMND or REVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Revelation Biosciences 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, CMND or REVB?

Clearmind Medicine is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Clearmind Medicine N/A N/A -$3.86M -$40.55 N/A Revelation Biosciences N/A N/A -$8.91M -$12.31 N/A

Is CMND or REVB more profitable?

Clearmind Medicine's return on equity of -88.53% beat Revelation Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -88.53% -61.62% Revelation Biosciences N/A -100.19% -82.72%

Is CMND or VCNX more profitable?

Vaccinex's return on equity of 0.00% beat Clearmind Medicine's return on equity. Company Net Margins Return on Equity Return on Assets Clearmind Medicine N/A -88.53% -61.62% Vaccinex N/A N/A -383.58%

Does the media favor CMND or VCNX?

In the previous week, Clearmind Medicine had 8 more articles in the media than Vaccinex. MarketBeat recorded 9 mentions for Clearmind Medicine and 1 mentions for Vaccinex. Clearmind Medicine's average media sentiment score of 0.55 beat Vaccinex's score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearmind Medicine 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vaccinex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Clearmind Medicine (CMND) Competitors

$6.23 0.00 (0.00%)

As of 01:22 PM Eastern

Compare

CMND vs. RDHL, CVKD, XRTX, REVB, and VCNX

Should you buy Clearmind Medicine stock or one of its competitors? Clearmind Medicine's main competitors and comparable companies include Redhill Biopharma (RDHL), Cadrenal Therapeutics (CVKD), XORTX Therapeutics (XRTX), Revelation Biosciences (REVB), and Vaccinex (VCNX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Clearmind Medicine compare to Redhill Biopharma?

Redhill Biopharma (NASDAQ:RDHL) and Clearmind Medicine (NASDAQ:CMND) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

Redhill Biopharma has a beta of 4.91, indicating that its stock price is 391% more volatile than the broader market. Comparatively, Clearmind Medicine has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market.

Redhill Biopharma has higher revenue and earnings than Clearmind Medicine.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Redhill Biopharma	$290K	10.80	-$430K	N/A	N/A
Clearmind Medicine	N/A	N/A	-$3.86M	-$40.55	N/A

7.2% of Redhill Biopharma shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 6.8% of Redhill Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Clearmind Medicine had 6 more articles in the media than Redhill Biopharma. MarketBeat recorded 9 mentions for Clearmind Medicine and 3 mentions for Redhill Biopharma. Clearmind Medicine's average media sentiment score of 0.55 beat Redhill Biopharma's score of 0.21 indicating that Clearmind Medicine is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Redhill Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Clearmind Medicine	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Redhill Biopharma's return on equity of 0.00% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Redhill Biopharma	N/A	N/A	N/A
Clearmind Medicine	N/A	-88.53%	-61.62%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Redhill Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Redhill Biopharma beats Clearmind Medicine on 7 of the 10 factors compared between the two stocks.

How does Clearmind Medicine compare to Cadrenal Therapeutics?

Clearmind Medicine (NASDAQ:CMND) and Cadrenal Therapeutics (NASDAQ:CVKD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, earnings, dividends and profitability.

Cadrenal Therapeutics has a consensus price target of $13.00, indicating a potential upside of 1,214.46%. Given Cadrenal Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Cadrenal Therapeutics is more favorable than Clearmind Medicine.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cadrenal Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Clearmind Medicine has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Cadrenal Therapeutics has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market.

In the previous week, Clearmind Medicine had 6 more articles in the media than Cadrenal Therapeutics. MarketBeat recorded 8 mentions for Clearmind Medicine and 2 mentions for Cadrenal Therapeutics. Cadrenal Therapeutics' average media sentiment score of 0.55 beat Clearmind Medicine's score of 0.55 indicating that Cadrenal Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clearmind Medicine	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cadrenal Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 7.9% of Cadrenal Therapeutics shares are held by institutional investors. 14.6% of Cadrenal Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cadrenal Therapeutics is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$40.55	N/A
Cadrenal Therapeutics	N/A	N/A	-$13.24M	-$4.90	N/A

Clearmind Medicine's return on equity of -88.53% beat Cadrenal Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-88.53%	-61.62%
Cadrenal Therapeutics	N/A	-406.41%	-273.80%

Summary

Cadrenal Therapeutics beats Clearmind Medicine on 7 of the 13 factors compared between the two stocks.

How does Clearmind Medicine compare to XORTX Therapeutics?

Clearmind Medicine (NASDAQ:CMND) and XORTX Therapeutics (NASDAQ:XRTX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Clearmind Medicine has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, XORTX Therapeutics has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Clearmind Medicine's return on equity of -88.53% beat XORTX Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-88.53%	-61.62%
XORTX Therapeutics	N/A	-137.85%	-108.16%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
XORTX Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 0.2% of XORTX Therapeutics shares are held by institutional investors. 6.9% of XORTX Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Clearmind Medicine had 4 more articles in the media than XORTX Therapeutics. MarketBeat recorded 8 mentions for Clearmind Medicine and 4 mentions for XORTX Therapeutics. XORTX Therapeutics' average media sentiment score of 1.02 beat Clearmind Medicine's score of 0.55 indicating that XORTX Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clearmind Medicine	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
XORTX Therapeutics	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

XORTX Therapeutics is trading at a lower price-to-earnings ratio than Clearmind Medicine, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$40.55	N/A
XORTX Therapeutics	N/A	N/A	-$2.66M	-$2.73	N/A

Summary

Clearmind Medicine beats XORTX Therapeutics on 6 of the 11 factors compared between the two stocks.

How does Clearmind Medicine compare to Revelation Biosciences?

Clearmind Medicine (NASDAQ:CMND) and Revelation Biosciences (NASDAQ:REVB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

In the previous week, Clearmind Medicine had 6 more articles in the media than Revelation Biosciences. MarketBeat recorded 8 mentions for Clearmind Medicine and 2 mentions for Revelation Biosciences. Clearmind Medicine's average media sentiment score of 0.55 beat Revelation Biosciences' score of 0.41 indicating that Clearmind Medicine is being referred to more favorably in the media.

Company	Overall Sentiment
Clearmind Medicine	Positive
Revelation Biosciences	Neutral

Clearmind Medicine has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market. Comparatively, Revelation Biosciences has a beta of -0.07, suggesting that its share price is 107% less volatile than the broader market.

Clearmind Medicine's return on equity of -88.53% beat Revelation Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-88.53%	-61.62%
Revelation Biosciences	N/A	-100.19%	-82.72%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clearmind Medicine	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Revelation Biosciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

96.1% of Clearmind Medicine shares are owned by institutional investors. Comparatively, 12.8% of Revelation Biosciences shares are owned by institutional investors. 4.8% of Revelation Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Clearmind Medicine is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$40.55	N/A
Revelation Biosciences	N/A	N/A	-$8.91M	-$12.31	N/A

Summary

Clearmind Medicine beats Revelation Biosciences on 7 of the 11 factors compared between the two stocks.

How does Clearmind Medicine compare to Vaccinex?

Clearmind Medicine (NASDAQ:CMND) and Vaccinex (NASDAQ:VCNX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

Clearmind Medicine has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, Vaccinex has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

96.1% of Clearmind Medicine shares are held by institutional investors. Comparatively, 50.1% of Vaccinex shares are held by institutional investors. 51.5% of Vaccinex shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Clearmind Medicine had 8 more articles in the media than Vaccinex. MarketBeat recorded 9 mentions for Clearmind Medicine and 1 mentions for Vaccinex. Clearmind Medicine's average media sentiment score of 0.55 beat Vaccinex's score of 0.00 indicating that Clearmind Medicine is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clearmind Medicine	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vaccinex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Clearmind Medicine has higher earnings, but lower revenue than Vaccinex. Clearmind Medicine is trading at a lower price-to-earnings ratio than Vaccinex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clearmind Medicine	N/A	N/A	-$3.86M	-$40.55	N/A
Vaccinex	$388K	7.04	-$20.25M	-$48.27	N/A

Vaccinex's return on equity of 0.00% beat Clearmind Medicine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clearmind Medicine	N/A	-88.53%	-61.62%
Vaccinex	N/A	N/A	-383.58%

Summary

Clearmind Medicine beats Vaccinex on 6 of the 11 factors compared between the two stocks.

Get Clearmind Medicine News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CMND vs. The Competition

Export

Metric	Clearmind Medicine	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.18M	$12.42B	$7.27B	$12.97B
Dividend Yield	N/A	2.63%	2.51%	22.89%
P/E Ratio	-0.15	807.81	275.40	25.37
Price / Sales	N/A	748.45	562.29	78.82
Price / Cash	N/A	86.65	77.16	53.04
Price / Book	0.05	9.21	10.55	5.95
Net Income	-$3.86M	$2.84B	$3.50B	$380.75M
7 Day Performance	-5.61%	-4.00%	-3.92%	-3.96%
1 Month Performance	-17.51%	-8.07%	-8.30%	-6.81%
1 Year Performance	-99.80%	-5.86%	2.35%	-4.58%

Clearmind Medicine Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CMND Clearmind Medicine	1.0101 of 5 stars	$6.23 flat	N/A	-99.8%	$3.18M	N/A	N/A	4	Short Interest Decrease Gap Up
RDHL Redhill Biopharma	0.832 of 5 stars	$0.64 +35.2%	N/A	-68.4%	$3.36M	$290K	N/A	210	News Coverage Gap Up
CVKD Cadrenal Therapeutics	2.8759 of 5 stars	$0.91 -6.9%	$13.00 +1,336.5%	-92.9%	$3.31M	N/A	N/A	5	Gap Up
XRTX XORTX Therapeutics	1.0188 of 5 stars	$1.76 +0.9%	N/A	-61.9%	$3.20M	N/A	N/A	N/A
REVB Revelation Biosciences	0.637 of 5 stars	$0.79 -4.4%	N/A	-86.4%	$3.15M	N/A	N/A	9	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CMND) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clearmind Medicine (CMND) Competitors

CMND vs. RDHL, CVKD, XRTX, REVB, and VCNX

How does Clearmind Medicine compare to Redhill Biopharma?

Summary

How does Clearmind Medicine compare to Cadrenal Therapeutics?

Summary

How does Clearmind Medicine compare to XORTX Therapeutics?

Summary

How does Clearmind Medicine compare to Revelation Biosciences?

Summary

How does Clearmind Medicine compare to Vaccinex?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMND vs. The Competition

Clearmind Medicine Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clearmind Medicine (CMND) Competitors

CMND vs. RDHL, CVKD, XRTX, REVB, and VCNX

How does Clearmind Medicine compare to Redhill Biopharma?

Which has more volatility and risk, RDHL or CMND?

Which has higher valuation and earnings, RDHL or CMND?

Do institutionals & insiders hold more shares of RDHL or CMND?

Does the media prefer RDHL or CMND?

Is RDHL or CMND more profitable?

Do analysts recommend RDHL or CMND?

Summary

How does Clearmind Medicine compare to Cadrenal Therapeutics?

Do analysts prefer CMND or CVKD?

Which has more volatility & risk, CMND or CVKD?

Does the media favor CMND or CVKD?

Do institutionals & insiders believe in CMND or CVKD?

Which has better earnings and valuation, CMND or CVKD?

Is CMND or CVKD more profitable?

Summary

How does Clearmind Medicine compare to XORTX Therapeutics?

Which has more risk & volatility, CMND or XRTX?

Is CMND or XRTX more profitable?

Do analysts rate CMND or XRTX?

Do insiders & institutionals hold more shares of CMND or XRTX?

Does the media prefer CMND or XRTX?

Which has higher earnings and valuation, CMND or XRTX?

Summary

How does Clearmind Medicine compare to Revelation Biosciences?

Does the media refer more to CMND or REVB?

Which has more risk & volatility, CMND or REVB?

Is CMND or REVB more profitable?

Do analysts rate CMND or REVB?

Do institutionals & insiders believe in CMND or REVB?

Which has preferable earnings & valuation, CMND or REVB?

Summary

How does Clearmind Medicine compare to Vaccinex?

Which has more volatility & risk, CMND or VCNX?

Do insiders and institutionals hold more shares of CMND or VCNX?

Does the media favor CMND or VCNX?

Which has stronger earnings & valuation, CMND or VCNX?

Is CMND or VCNX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMND vs. The Competition

Clearmind Medicine Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools